Skip to main content

Table 2 Vaccine immune response monitoring in previously infected and not previously infected cohorts of healthcare providers

From: Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

 

Pre

Post I

Post II

Median (IR) BAU/mL

Previously infected subjects

36.6 (14.5–99.0)

> 2500.0

–

Not previously infected subjects

< 0.4

18.9 (4.3–58.2)

2111.0 (713.8 - > 2500.0)

  1. Previously infected subjects = subjects infected to SARS-CoV-2
  2. Not previously infected subjects = subjects not infected to SARS-CoV-2
  3. Pre = anti - SARS-CoV-2 S titers before the first dose
  4. Post I = anti - SARS-CoV-2 S titers 20 days after the first dose
  5. Post II = anti - SARS-CoV-2 S titers 8 days after the second dose
  6. median = median of anti - SARS-CoV-2 S titers
  7. IR = Interquartile Range of anti - SARS-CoV-2 S titers
Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us